Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 36626583

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2023 Apr 20
First author
Song Y

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Song Y
      type
      Author
    2. name
      Tilly H
      type
      Author
    3. name
      Rai S
      type
      Author
    4. name
      Zhang H
      type
      Author
    5. name
      Jin J
      type
      Author
    6. name
      Goto H
      type
      Author
    7. name
      Terui Y
      type
      Author
    8. name
      Shin HJ
      type
      Author
    9. name
      Kim WS
      type
      Author
    10. name
      Cao J
      type
      Author
    11. name
      Feng J
      type
      Author
    12. name
      Eom HS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Song Y
      type
      Author
    2. name
      Tilly H
      type
      Author
    3. name
      Rai S
      type
      Author
    4. name
      Zhang H
      type
      Author
    5. name
      Jin J
      type
      Author
    6. name
      Goto H
      type
      Author
    7. name
      Terui Y
      type
      Author
    8. name
      Shin HJ
      type
      Author
    9. name
      Kim WS
      type
      Author
    10. name
      Cao J
      type
      Author
    11. name
      Feng J
      type
      Author
    12. name
      Eom HS
      type
      Author
    bibliography ids
    1. nci-bib-b50b0c2847a2295d948f010a
    book metadata
    content sha256
    657ca4990a9403ed833ba1356b8475f5196500b2f97d1c556a9d155f39320596
    document type
    citation
    dois
    1. 10.1182/blood.2022017734
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:36626583
    immutable id
    pubmed:36626583@657ca4990a9403ed833ba1356b8475f5196500b2f97d1c556a9d155f39320596
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    16
    name
    Blood
    nlm unique id
    7603509
    pages
    1971-1981
    volume
    141
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      36626583
      provenance
      batch id
      d370e99271168e8a8a13
      provider
      NCBI PubMed ESummary
      record sha256
      8fd149281b954587762f8052b1b3ddcc7d50fe105ac775c3b48f5005afa7c561
      response sha256
      f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
      retrieved at
      2026-09-09T23:48:13.005737+00:00
      publication date
      display
      2023 Apr 20
      precision
      day
      year
      2023
      publication types
      1. Randomized Controlled Trial
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/36626583/
      title
      Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice